No invoice? Only a receipt?

(0) 讚！ | Tonyy818

Is the article on viral gastroenteritis a good pitch?

(0) 讚！ | 京城子儒

Hello, can I ask for the specific requirements for the image format? Mine is in tif format, with a dpi of 1000. I'm not sure why they say my image is not up to standard, and that the generated pdf does not have embedded content.

(0) 讚！ | aimer yy

Can I make modifications and resubmit after being rejected?

(0) 讚！ | gdzyb

It would be good if we could score 4 or 5 out of 25 years!

(1) 讚！ | 德云小生

Are you comparing this journal with NC? They are not even on the same level!

(1) 讚！ | 德云小生

What's wrong with this submission system? I couldn't generate a PDF in the end, so I had to click complete directly, but it was sent back... But even after trying again, I still couldn't generate a PDF...

(0) 讚！ | Jessie_Lu

How do you know what progress is under review?

(0) 讚！ | Tonyy818

Rejected on April 10th, it took one month. Although it has been under review status the whole time, it has also been through the peer review process. The two editors in the email also gave very constructive feedback. Hope it helps you

(0) 讚！ | 阳光雨露dyd

Submitted on March 5th, still Under Review as of April 7th. Teachers, is it normal to stay in this status before revisions?

(0) 讚！ | 阳光雨露dyd

Review speed: 2.0 | Submission acceptance rate: 25.0
Emphasized research direction: COVID-19 Experience Sharing: Submitted one paper, received major revisions, hoping for good luck

(0) 讚！ | 桃花永莲

According to justscience's prediction, this magazine will have no impact factor in June 2024

(0) 讚！ | 仲夏美媛

This bird magazine suddenly soared from a score of 2 to over 20, something fishy must be going on. It's totally a spam magazine, probably will be kicked out of SCI like oncotarget in a few years

(0) 讚！ | 仲夏美媛

Good magazine, can choose non-OA no page charges, I have not paid a penny of page charges, which is much better than paying to publish in Nature Communications

(0) 讚！ | aakaifeung

Have you resubmitted your revised manuscript for review? After one rejection and some minor revisions, the final editor still rejected it. Are you planning to resubmit it after making changes based on the reviewer's feedback? Have you had a similar experience? Any tips on what to pay attention to?

(1) 讚！ | lililililili66

Initial Submission This submission is under consideration and cannot be edited. It has been in this status for more than a week, what does it mean? Has it been reviewed?

(0) 讚！ | 水月尔阳

Have you appealed? Can you resubmit and try again?

(0) 讚！ | 破戒青文

Received, scored 12.7, ranked second in virology journals, some reviewers' suggestions are quite insightful

(9) 讚！ | sdafaefwefwq

Review speed: 3.0 | Submission hit rate: 50.0
Emphasis on research direction: pharmaceutical experience sharing: My research workload is relatively heavy. The editor gave a major revision and a minor revision, and then accepted it. Overall, the reviewers' comments were very fair, and I also gained some new insights. I have also submitted two articles with smaller workloads, but neither was accepted, so it seems that the journal still has certain requirements for quality. I hope the journal can maintain its rating of 12 points, after all, it is the second-ranked journal in virology

(0) 讚！ | 苍风悦乐

This magazine was not very good to begin with, and it only managed to bump up to a 2 rating. It's only a matter of time before it goes back down. Next year, it will probably be lucky to have a 6. Just look at the quality of the articles above and you'll understand

(0) 讚！ | 晨

Review Speed: 2.0 | Submission Acceptance Rate: 75.0
Emphasized Research Direction: Experiment; COVID-19; Clinical Experience Sharing: Submitted in October, minor revisions in early December, accepted by the end of December. Overall, the speed is very fast, and the reviewers' comments are constructive

(0) 讚！ | Payne Bryan

If you score more than 12 points, will you be in the top three areas of the Chinese Academy of Sciences? Haha! I did not submit any papers!

(8) 讚！ | 德云小生

Review Speed: 3.0 | Submission Acceptance Rate: 75.0 Weighted Research Direction: COVID-19; Clinical Experience Sharing: Submitted at the end of August, received major revision comments at the end of September, revised in early November, accepted in early December, online for half a month

(0) 讚！ | 卧龙冷旋

Focused research area: vaccines; COVID-19; virology
Virology Journal is in the second zone of the Chinese Academy of Sciences. It doesn't make sense that you've always been in the third zone of the Chinese Academy of Sciences

(0) 讚！ | 暴风嘉赐

I feel that this journal might move up to the second tier of the Chinese Academy of Sciences or even higher in the future. It could be a good investment to submit to it now!

(0) 讚！ | 德云小生